Peer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
10
1kṀ2493
2026
66%
chance
21

Particularly against severe / pandemic-risk disease such as CoV-2, H5N1, or so on.

Resolves YES if one is published which shows statistically significant effects using mushroom or mycelium-derived extracts or compounds. Otherwise NO at end of 2026.

Get
Ṁ1,000
to start trading!
Sort by:
opened a Ṁ2,000 NO at 50% order

fairly wide but generous limits up for traders

© Manifold Markets, Inc.TermsPrivacy